194 related articles for article (PubMed ID: 27464743)
1. Comparative analysis of pharmacological properties of xanomeline and N-desmethylclozapine in rat brain membranes.
Odagaki Y; Kinoshita M; Ota T
J Psychopharmacol; 2016 Sep; 30(9):896-912. PubMed ID: 27464743
[TBL] [Abstract][Full Text] [Related]
2. Effect of muscarinic receptor agonists xanomeline and sabcomeline on acetylcholine and dopamine efflux in the rat brain; comparison with effects of 4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one (AC260584) and N-desmethylclozapine.
Li Z; Snigdha S; Roseman AS; Dai J; Meltzer HY
Eur J Pharmacol; 2008 Oct; 596(1-3):89-97. PubMed ID: 18771666
[TBL] [Abstract][Full Text] [Related]
3. Striatal, Hippocampal, and Cortical Networks Are Differentially Responsive to the M4- and M1-Muscarinic Acetylcholine Receptor Mediated Effects of Xanomeline.
Thorn CA; Moon J; Bourbonais CA; Harms J; Edgerton JR; Stark E; Steyn SJ; Butter CR; Lazzaro JT; O'Connor RE; Popiolek M
ACS Chem Neurosci; 2019 Mar; 10(3):1753-1764. PubMed ID: 30480428
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of M1 muscarinic acetylcholine receptor-mediated Gq activation in rat cerebral cortical and hippocampal membranes.
Odagaki Y; Kinoshita M; Toyoshima R
Naunyn Schmiedebergs Arch Pharmacol; 2013 Nov; 386(11):937-47. PubMed ID: 23748234
[TBL] [Abstract][Full Text] [Related]
5. Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors.
Watson J; Brough S; Coldwell MC; Gager T; Ho M; Hunter AJ; Jerman J; Middlemiss DN; Riley GJ; Brown AM
Br J Pharmacol; 1998 Dec; 125(7):1413-20. PubMed ID: 9884068
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological assessment of m1 muscarinic acetylcholine receptor-gq/11 protein coupling in membranes prepared from postmortem human brain tissue.
Salah-Uddin H; Thomas DR; Davies CH; Hagan JJ; Wood MD; Watson JM; Challiss RA
J Pharmacol Exp Ther; 2008 Jun; 325(3):869-74. PubMed ID: 18322150
[TBL] [Abstract][Full Text] [Related]
7. In Vivo Pharmacological Comparison of TAK-071, a Positive Allosteric Modulator of Muscarinic M
Mandai T; Kasahara M; Kurimoto E; Tanaka M; Suzuki M; Nakatani A; Kimura H
Neuroscience; 2019 Aug; 414():60-76. PubMed ID: 31299348
[TBL] [Abstract][Full Text] [Related]
8. AC260584 (4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one), a selective muscarinic M1 receptor agonist, increases acetylcholine and dopamine release in rat medial prefrontal cortex and hippocampus.
Li Z; Bonhaus DW; Huang M; Prus AJ; Dai J; Meltzer HY
Eur J Pharmacol; 2007 Oct; 572(2-3):129-37. PubMed ID: 17628522
[TBL] [Abstract][Full Text] [Related]
9. Functional activation of G-proteins coupled with muscarinic acetylcholine receptors in rat brain membranes.
Odagaki Y; Kinoshita M; Toyoshima R
J Pharmacol Sci; 2014; 125(2):157-68. PubMed ID: 24849282
[TBL] [Abstract][Full Text] [Related]
10. Wash-resistantly bound xanomeline inhibits acetylcholine release by persistent activation of presynaptic M(2) and M(4) muscarinic receptors in rat brain.
Machová E; Jakubík J; El-Fakahany EE; Dolezal V
J Pharmacol Exp Ther; 2007 Jul; 322(1):316-23. PubMed ID: 17446301
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological evidence showing muscarinic agonist-antagonist activities of N-desmethylclozapine using hippocampal excitatory and inhibitory neurons.
Sugawara Y; Kikuchi Y; Yoneda M; Ohno-Shosaku T
Brain Res; 2016 Jul; 1642():255-262. PubMed ID: 27048752
[TBL] [Abstract][Full Text] [Related]
12. Muscarinic receptor signaling contributes to atypical antipsychotic drug reversal of the phencyclidine-induced deficit in novel object recognition in rats.
Miyauchi M; Neugebauer NM; Sato T; Ardehali H; Meltzer HY
J Psychopharmacol; 2017 Dec; 31(12):1588-1604. PubMed ID: 28946779
[TBL] [Abstract][Full Text] [Related]
13. N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl-D-aspartate receptor activity.
Sur C; Mallorga PJ; Wittmann M; Jacobson MA; Pascarella D; Williams JB; Brandish PE; Pettibone DJ; Scolnick EM; Conn PJ
Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13674-9. PubMed ID: 14595031
[TBL] [Abstract][Full Text] [Related]
14. Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
Bymaster FP; Wong DT; Mitch CH; Ward JS; Calligaro DO; Schoepp DD; Shannon HE; Sheardown MJ; Olesen PH; Suzdak PD; Swedberg MD; Sauerberg P
J Pharmacol Exp Ther; 1994 Apr; 269(1):282-9. PubMed ID: 7909558
[TBL] [Abstract][Full Text] [Related]
15. Differences in kinetics of xanomeline binding and selectivity of activation of G proteins at M(1) and M(2) muscarinic acetylcholine receptors.
Jakubík J; El-Fakahany EE; Dolezal V
Mol Pharmacol; 2006 Aug; 70(2):656-66. PubMed ID: 16675658
[TBL] [Abstract][Full Text] [Related]
16. The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat.
Stanhope KJ; Mirza NR; Bickerdike MJ; Bright JL; Harrington NR; Hesselink MB; Kennett GA; Lightowler S; Sheardown MJ; Syed R; Upton RL; Wadsworth G; Weiss SM; Wyatt A
J Pharmacol Exp Ther; 2001 Nov; 299(2):782-92. PubMed ID: 11602695
[TBL] [Abstract][Full Text] [Related]
17. 5-HT1A receptor agonist properties of antipsychotics determined by [35S]GTPgammaS binding in rat hippocampal membranes.
Odagaki Y; Toyoshima R
Clin Exp Pharmacol Physiol; 2007; 34(5-6):462-6. PubMed ID: 17439416
[TBL] [Abstract][Full Text] [Related]
18. The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine.
Weiner DM; Meltzer HY; Veinbergs I; Donohue EM; Spalding TA; Smith TT; Mohell N; Harvey SC; Lameh J; Nash N; Vanover KE; Olsson R; Jayathilake K; Lee M; Levey AI; Hacksell U; Burstein ES; Davis RE; Brann MR
Psychopharmacology (Berl); 2004 Dec; 177(1-2):207-16. PubMed ID: 15258717
[TBL] [Abstract][Full Text] [Related]
19. The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine's actions?
Davies MA; Compton-Toth BA; Hufeisen SJ; Meltzer HY; Roth BL
Psychopharmacology (Berl); 2005 Apr; 178(4):451-60. PubMed ID: 15765260
[TBL] [Abstract][Full Text] [Related]
20. Behavioral effects of N-desmethylclozapine on locomotor activity and sensorimotor gating function in mice-Possible involvement of muscarinic receptors.
Maehara S; Hikichi H; Ohta H
Brain Res; 2011 Oct; 1418():111-9. PubMed ID: 21917240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
